Cargando…

High resolution 16S rRNA gene Next Generation Sequencing study of brain areas associated with Alzheimer’s and Parkinson’s disease

INTRODUCTION: Alzheimer’s (AD) and Parkinson’s disease (PD) are neurodegenerative conditions characterized by incremental deposition of β-amyloid (Aβ) and α-synuclein in AD and PD brain, respectively, in relatively conserved patterns. Both are associated with neuroinflammation, with a proposed micro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Emery, David C., Davies, Maria, Cerajewska, Tanya L., Taylor, Jelena, Hazell, Mae, Paterson, Alex, Allen-Birt, Shelley J., West, Nicola X.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780557/ https://www.ncbi.nlm.nih.gov/pubmed/36570533 http://dx.doi.org/10.3389/fnagi.2022.1026260

Ejemplares similares

16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer’s Post-Mortem Brain
por: Emery, David C., et al.
Publicado: (2017)

Comparison of Blood Bacterial Communities in Periodontal Health and Periodontal Disease
por: Emery, David C., et al.
Publicado: (2021)

Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023)

Identifying prodromal symptoms at high specificity for Parkinson’s disease
por: Jackson, Holly, et al.
Publicado: (2023)

Editorial: Translational Advances in Alzheimer's, Parkinson's, and Other Neurodegenerative Dementias
por: Jiang, Jiehui, et al.
Publicado: (2022)

Somatic Mutations Detected in Parkinson Disease Could Affect Genes With a Role in Synaptic and Neuronal Processes
por: Lobon, Irene, et al.
Publicado: (2022)

Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease
por: Lu, Ranran, et al.
Publicado: (2022)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

Removal of p16 ( INK4 ) Expressing Cells in Late Life has Moderate Beneficial Effects on Skeletal Muscle Function in Male Mice
por: Guzman, Steve D., et al.
Publicado: (2022)

Whole exome sequencing identified a new compound heterozygous PRKN mutation in a Chinese family with early-onset Parkinson’s disease
por: Li, Tianbai, et al.
Publicado: (2020)

Application of 16S rRNA next generation sequencing in ticks in Greece
por: Papa, Anna, et al.
Publicado: (2020)

Exploring the Hospital Microbiome by High-Resolution 16S rRNA Profiling
por: Rampelotto, Pabulo H., et al.
Publicado: (2019)

Loop diuretics association with Alzheimer’s disease risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Editorial: Translational advances in Alzheimer's, Parkinson's, and other dementia: Molecular mechanisms, biomarkers, diagnosis, and therapies, volume II
por: Jiang, Jiehui, et al.
Publicado: (2022)

G-quadruplexes and associated proteins in aging and Alzheimer’s disease
por: Vijay Kumar, M. J., et al.
Publicado: (2023)

A 16-Week Aerobic Exercise Intervention Does Not Affect Hippocampal Volume and Cortical Thickness in Mild to Moderate Alzheimer’s Disease
por: Frederiksen, Kristian Steen, et al.
Publicado: (2018)

Exendin-4 alleviates β-Amyloid peptide toxicity via DAF-16 in a Caenorhabditis elegans model of Alzheimer's disease
por: Song, Xiangwei, et al.
Publicado: (2022)

Normative mice retinal thickness: 16-month longitudinal characterization of wild-type mice and changes in a model of Alzheimer's disease
por: Batista, Ana, et al.
Publicado: (2023)

Editorial: Molecular mechanisms of Alzheimer’s disease: From top to bottom
por: Mello-Carpes, Pâmela B., et al.
Publicado: (2022)

Neuropathology of Aging in Cats and its Similarities to Human Alzheimer’s Disease
por: Sordo, Lorena, et al.
Publicado: (2021)

Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer’s Disease
por: Cox, MaKayla F., et al.
Publicado: (2022)

Amyloid-β in Alzheimer’s disease – front and centre after all?
por: Weglinski, Caroline, et al.
Publicado: (2023)

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019)

Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Xiang, Shuai, et al.
Publicado: (2022)

The role of microglial autophagy in Parkinson’s disease
por: Zhu, Rui, et al.
Publicado: (2022)

Sex Differences in Large Artery Stiffness: Implications for Cerebrovascular Dysfunction and Alzheimer’s Disease
por: Kehmeier, Mackenzie N., et al.
Publicado: (2021)

Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review
por: Schreiner, Oliver Daniel, et al.
Publicado: (2023)

Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease
por: Yu, Weiwei, et al.
Publicado: (2021)

Impact of alcohol-induced intestinal microbiota dysbiosis in a rodent model of Alzheimer’s disease
por: Frausto, Dulce M., et al.
Publicado: (2022)

Highlighting the value of Alzheimer’s disease-focused registries: lessons learned from cancer surveillance
por: Miller, Margaret C., et al.
Publicado: (2023)

Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease
por: Delgado-Álvarez, Alfonso, et al.
Publicado: (2023)

Effects of DISC1 on Alzheimer’s disease cell models assessed by iTRAQ proteomics analysis
por: Lu, Jiajie, et al.
Publicado: (2022)

A Roadmap for Future Parkinson's Pharmacogenomics in Asia
por: Akbar, Muhammad, et al.
Publicado: (2022)

Impact of aging on animal models of Parkinson's disease
por: Klæstrup, Ida Hyllen, et al.
Publicado: (2022)

Editorial: Genetic and molecular diversity in Parkinson's disease
por: Abdul Murad, Nor Azian, et al.
Publicado: (2022)

Oculomotor impairments in de novo Parkinson’s disease
por: Zhou, Meng-Xi, et al.
Publicado: (2022)

Precision medicine for Parkinson’s disease: The subtyping challenge
por: Frasier, Mark, et al.
Publicado: (2022)

Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer’s disease patient lymphocytes
por: Wang, Hoau-Yan, et al.
Publicado: (2023)

Roadmap for Sex-Responsive Influenza and COVID-19 Vaccine Research in Older Adults
por: Shapiro, Janna R., et al.
Publicado: (2022)

The Occurrence of Alzheimer’s Disease and Parkinson’s Disease in Individuals With Osteoporosis: A Longitudinal Follow-Up Study Using a National Health Screening Database in Korea
por: Kwon, Mi Jung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_stojb8gikvio42vi5bka5bd7ut